Fig. 5From: Evaluation of serum tRF-23-Q99P9P9NDD as a potential biomarker for the clinical diagnosis of gastric cancerDiagnostic value of serum tRF-23-Q99P9P9NDD for GC. A–C The diagnostic efficacy of tRF-23-Q99P9P9NDD, CEA, CA199, and CA724 in differentiating GC patients from healthy donors. D–F The diagnostic efficacy of tRF-23-Q99P9P9NDD, CEA, CA199, and CA724 in differentiating early GC patients from healthy donors was determined by ROC analysis. G–I The diagnostic efficacy of tRF-23-Q99P9P9NDD, CEA, CA199, and CA724 in differentiating GC patients from gastritis patients was determined by ROC analysisBack to article page